Can-Fite BioPharma Ltd. (TLV: CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA
2.700
0.00 (0.00%)
Nov 17, 2024, 3:36 PM IDT
Can-Fite BioPharma Employees
Can-Fite BioPharma had 8 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
313.92K ILS
Profits / Employee
-3.47M ILS
Market Cap
53.15M
Employees Chart
Can-Fite BioPharma News
- 8 days ago - Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial - GlobeNewsWire
- 15 days ago - Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia - GlobeNewsWire
- 4 weeks ago - Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson - GlobeNewsWire
- 5 weeks ago - Can-Fite stock rallies 17% on FDA orphan drug designation - Seeking Alpha
- 5 weeks ago - FDA Grants Orphan Drug Designation to Can-Fite's Namodenoson for Pancreatic Cancer - GlobeNewsWire
- 2 months ago - Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health - GlobeNewsWire
- 2 months ago - Can-Fite BioPharma files to sell 1.77B shares of common stock for holders - Seeking Alpha
- 2 months ago - Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.32M - Seeking Alpha